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ReviewPluripotent cells have the potential to differentiate into
all of the cell types of an animal. This unique cell state is
governed by an interconnected network of transcription
factors. Among these, Oct4 plays an essential role both
in the development of pluripotent cells in the embryo
and in the self-renewal of its in vitro counterpart, embry-
onic stem (ES) cells. Furthermore, Oct4 is one of the four
Yamanaka factors and its overexpression alone can gen-
erate induced pluripotent stem (iPS) cells. Recent
reports underscore Oct4 as an essential regulator of
opposing cell state transitions, such as pluripotency
establishment and differentiation into embryonic germ
lineages. Here we discuss these recent studies and the
potential mechanisms underlying these contrasting
functions of Oct4.
Oct4 in pluripotency
Cell identity is characterised by a stable, unique, self-
sustaining gene expression pattern. Cell state transition
represents a change from one cell identity to another. Such
transitions occur in development during differentiation
into progressively specialised cell types, which is accompa-
nied by a gradual restriction of developmental potential.
Pluripotency characterises the cells capable of giving rise
to all of the cell types of an organism except for extraem-
bryonic tissues [1,2]. In mouse embryos, pluripotent cells
emerge in the epiblast during preimplantation develop-
ment and, shortly after implantation, undergo differentia-
tion into embryonic germ layers and the germline. The
pluripotent cells in the preimplantation embryo are con-
sidered naı¨ve as opposed to the primed pluripotent cells of
the postimplantation embryo, because they have unbiased
developmental potential and can give rise to germline-
competent chimeras when reintroduced into a blastocyst
[3]. The in vitro counterparts of this transient naı¨ve0962-8924     
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Open access under CC BY license.pluripotent cell population are ES cells. Similarly to the
naı¨ve epiblast, ES cells coexpress the pluripotency markers
Esrrb, Nanog, Rex1, Klf4, Klf2, Sox2, Tbx3, Tfcp2l1, and
Oct4, have two active X chromosomes in the case of female
cells, and can give rise to fully ES cell-derived mice [4].
Although cell state transitions are typically perceived as
moving from a less differentiated to a more differentiated
state, groundbreaking work by Takahashi and Yamanaka
demonstrated that the cell state transition from somatic
cells to naı¨ve pluripotency is also possible and can be
induced by the overexpression of four transcription factors:
Oct4, Sox2, Klf4, and c-Myc [5]. The derived cells were
named iPS cells and they have since been obtained from
different species and types of somatic cells. Although the
method of reprogramming is firmly established, the molec-
ular mechanisms underlying this process remain poorly
characterised.
Among the four original reprogramming factors, the
POU family transcription factor Oct4 appears to be the
most important pluripotency regulator. Oct4 was found to
be required for the formation of the naı¨ve epiblast, because
the inner cell mass of Oct4-null embryos lacks pluripotent
characteristics [6]. In addition, abrogation of Oct4 expres-
sion in ES cells leads to their differentiation along the
trophoblast lineage [7]. Although the SRY-related HMG-
box transcription factor Sox2 has also been shown to
possess a loss-of-function phenotype similar to that of
Oct4 in both embryos [8] and ES cells [9], ectopic expres-
sion of wild type levels of Oct4 can rescue the Sox2-null
phenotype in ES cells [9]. This result indicates that Oct4
activation may be the sole essential function of Sox2 in ES
cell self-renewal. In contrast to Oct4 and Sox2, other
pluripotency factors seem to be individually dispensable
for the maintenance of the naı¨ve pluripotent state [10–15].
Overexpression of Nanog [16], Esrrb [17], Klf4, Klf2 [18],
Tfcp2l1 [15], and Tbx3 [19] leads to enhanced self-renewal
of ES cells, illustrating a positive effect on the pluripotent
network. In turn, overexpression of Oct4 or Sox2 leads to
spontaneous ES cell differentiation [7,20].
Recent studies are revealing novel aspects of the biolog-
ical functions of Oct4. Particularly, Oct4 was found to
regulate seemingly opposite processes of cell identity
change: the induction of pluripotency from somatic cells,
pluripotent cell differentiation into embryonic lineages,Trends in Cell Biology, May 2014, Vol. 24, No. 5 275
Review Trends in Cell Biology May 2014, Vol. 24, No. 5and transdifferentiation – that is, the conversion of one
somatic cell type into another without a common progeni-
tor. In this review, we discuss these recent studies and the
potential molecular mechanisms underlying these con-
trasting roles of Oct4 and propose that Oct4 is an essential
regulator of cell state transitions in development.
Oct4 in reprogramming
In addition to being an essential regulator of pluripotency,
Oct4 is also central to nuclear reprogramming. Oct4 over-
expression is sufficient to induce pluripotency when using
somatic cell types expressing canonical reprogrammingTable 1. Reprogramming cocktails without Oct4
Alternative reprogramming cocktail Somatic cell type 
KSM + BIX-01294 Primary mouse fetal neu
progenitor cells
KSM + Nr5a1
KSM + Nr5a2
Mouse embryonic fibro
KSM + Tet1 Mouse embryonic fibro
KSM + Sall4 + Nanog
KM + Lin28 + Sall4 + Esrrb + Nanog
KM + Lin28 + Sall4 + Ezh2 + Nanog
Lin28 + Sall4 + Esrrb + Nanog
Lin28 + Sall4 + Esrrb + Dppa2
Mouse embryonic fibro
KSM + Gata3 Mouse embryonic fibro
Mouse adult dermal fib
Mouse gastric epithelial
Mouse keratinocytes
KSM + Sox7
KSM + Pax1
KSM + Gata4
KSM + CEBPa
KSM + HNF4a
KSM + GRB2
KM + Gata3 + Sox1
KM + Gata3 + Sox3
KM + Gata6 + Sox1
KM + Gata6 + Sox3
KM + Pax1 + Sox1
KM + Pax1 + Sox3
Mouse adult dermal fib
KSM + Gata6 Mouse adult dermal fib
Mouse keratinocytes
KM + Gata6 + Geminin Mouse adult dermal fib
Mouse embryonic fibro
KSVPM + Gata3VP Primary human foreskin
KSM + E-cadherin Mouse embryonic fibro
KSM + forskolin
KSM + 2-methyl-5-hydroxytryptamine
KSM + D4476
Mouse embryonic fibro
VPA + CHIR99021 + 616452 +
tranylcypromine + forskolin + DZNep
Mouse embryonic fibro
Mouse neonatal fibrobla
Mouse adult fibroblasts
Adipose-derived stem c
KSM + human Oct4
KSM + Xenopus Oct91
KSM + medaka Pou2
KSM + axolotl Oct4
KSM + axolotl Pou2
Mouse embryonic fibro
KSM + axolotl Oct4
KSM + axolotl Pou2
KM + axolotl Oct4 + axolotl Sox2
KM + axolotl Pou2 + axolotl Sox2
Primary human skin fib
KSM + A-OD3 (TALE-based designer
transcriptional activator of Oct4)
Mouse embryonic fibro
The table lists all studies that have reported reprogramming cocktails not containing 
transcriptional activator VP.
276factors endogenously [21–24] or when in combination with
small molecules [25–27]. However, reprogramming with
Oct4 alone exhibits decreased efficiency and delayed kinet-
ics. Significantly, exogenous Oct4 was shown to be replace-
able in initiating reprogramming; however, most of the
factors and small molecules demonstrated to do this (Table
1) act by reactivating the endogenous Oct4 locus. The
nuclear receptors Nr5a1 and Nr5a2, which were shown
to induce pluripotency in the absence of Oct4 [28], bind
regulatory regions of the Oct4 gene and activate its expres-
sion in ES cells and embryonic carcinoma (EC) cells [29,30].
Tet1 was recently demonstrated to replace exogenous Oct4Refs Evidence of acting through
endogenous Oct4?
ral [64] Yes
blasts [28] Yes
blasts [31] Yes
blasts [33] Yes
blasts
roblasts
 cells
[68] No
roblasts
roblasts
roblasts
blasts
 fibroblasts [69] Yes
blasts [54] No
blasts [118] No
blasts
sts
ells
blasts
[43]
Act by direct substitution
of Oct4 due to structural
and functional homology
roblasts
blasts [37] Yes
Oct4. Abbreviations: K, Klf4; S, Sox2; M, c-Myc; VP, indicates a protein fused to a
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the Oct4 regulatory regions and, thereby, to contribute
towards the reactivation of the endogenous locus [31]. In
addition, Tet1 together with Nanog was found to synergis-
tically activate the endogenous Oct4 locus in reprogram-
ming intermediates [32]. Oct4 is also not required to
initiate reprogramming when the following transgene com-
binations are used: (i) Sox2, Sall4, Nanog, Klf4, C-Myc; (ii)
Lin28, Sall4, Esrrb, Nanog, Klf4, c-Myc; (iii) Lin28, Sall4,
Esrrb, Nanog; (iv) Lin28, Sall4, Esrrb, Dppa2; (v) Lin28,
Sall4, Ezh2, Nanog, Klf4, c-Myc [33]; and (vi) Sall1, Sall4,
Utf1, c-Myc, Nanog [34]. Notably, all of the combinations
contain Sall4 as a reprogramming factor and Bayesian
network analysis positions Sall4 upstream of Oct4 in the
sequence of events leading to the establishment of naı¨ve
pluripotency [33]. Moreover, Sall4 was previously reported
to positively affect the expression of Oct4 in both mouse
and human ES cells [35,36], suggesting that Sall4 may
activate Oct4 during reprogramming. Importantly, it was
recently demonstrated that an overexpression of a custom-
made transcription activator targeting the Oct4 enhancer
leads to strong activation of the endogenous Oct4 locus and
efficient iPS cell generation in the absence of Oct4 in the
reprogramming cocktail [37]. This finding proves that any
factor capable of activating Oct4 expression could replace it
in reprogramming.
Whereas Sox2, Klf4, and c-Myc can be replaced by their
family members during reprogramming, octamer-binding
POU family members Oct1 and Oct6 cannot replace Oct4
[38]. In addition, Oct1, Oct2, and Oct6 cannot sustain
pluripotency in Oct4-null mouse ES cells [39]. The unique
requirement for Oct4 function in reprogramming, as op-
posed to other POU family members, was recently attrib-
uted to the linker region connecting the two DNA-binding
domains of the protein [40]. Mutation of the key amino
acids in this linker led to complete abrogation of Oct4
reprogramming ability, while having no effect on its
DNA binding, transactivation potential, or nuclear locali-
zation. Further analysis demonstrated that these key
amino acids are located at the surface of the protein and
are potentially involved in the recruitment of epigenetic
modifiers to Oct4 target genes [40].
Several reports investigated the evolutionary conserva-
tion of Oct4 as a reprogramming factor. According to the
current view, Oct4 (also known as Pou5f1) and its paralog
Pou5f3 (also known as Pou2) arose by gene duplication at
least as early as the last common ancestor of gnathostomes
[41]. Oct4 was subsequently lost in teleost fish, anurans,
crocodilians, and birds. In turn, Pou5f3 was lost in squa-
mate reptiles and eutherian mammals, whereas marsu-
pials, monotremes, urodeles, coelacanths, and turtles
retained both genes [41,42]. Tested Oct4 orthologues, hu-
man and axolotl, were shown to replace exogenous mouse
Oct4 in reprogramming [43]. Among the Pou5f3 ortholo-
gues, the ability to initiate reprogramming in the mouse
system was found for medaka, axolotl, and Xenopus but not
zebrafish [43]. Importantly, human, axolotl and Xenopus
but not zebrafish Oct4 homologues can also maintain ES
cell self-renewal in the absence of endogenous Oct4 [44,45].
In turn, overexpression of mouse or human Oct4 in combi-
nation with other Yamanaka factors in avian, zebrafish,and fly somatic cells leads to the upregulation of endoge-
nous pluripotency gene homologues and the formation of
partially reprogrammed cells [46,47]. Together, these
results demonstrate functional conservation between
Oct4 homologues.
In summary, Oct4 is a powerful reprogramming factor
with evolutionarily conserved functions that are non-re-
dundant within the POU gene family.
Molecular mechanisms of Oct4 in reprogramming
Despite its established importance for reprogramming, the
precise mechanism of Oct4 action during this process
remains unclear. Experimental evidence suggests that
Oct4 participates in the induction of the mesenchymal-
to-epithelial transition (MET) and in the derepression of
somatic cell chromatin. In addition, Oct4 in cooperation
with Sox2 was proposed to prevent the acquisition of
alternative cell states during reprogramming. Further-
more, Oct4 dose and cellular localisation were proposed
as important parameters of successful reprogramming.
Facilitating the MET
Acquisition of an epithelial phenotype by mesenchymal
cells, or the MET, is a hallmark of reprogramming initia-
tion [48]. The importance of this process is illustrated by
the abrogation of reprogramming in response to MET
inhibition and by its enhancement on MET induction
[49–52]. All four Yamanaka factors are involved in differ-
ent aspects of MET regulation. Oct4 was shown to down-
regulate the epithelial-to-mesenchymal transition (EMT)
regulator Snail via the repression of Tgfb3 and TgfbR3 [52]
and, together with Sox2, to activate a specific cluster of the
miR-200 miRNA family that in turn represses the expres-
sion of the EMT regulator Zeb2 [53], thereby facilitating
the MET (Figure 1A). Interestingly, overexpression of the
MET regulator E-cadherin was shown to replace exoge-
nous Oct4 in reprogramming [54]. This substitution, how-
ever, cannot be completely explained by compensation for
the role of Oct4 in MET induction, because chemical inhi-
bition of the EMT cannot replace Oct4 in the reprogram-
ming cocktail [49,50]. E-cadherin overexpression may also
favour reprogramming via b-catenin sequestration at the
membrane and, thereby, inhibition of canonical Wnt-sig-
nalling, because Wnt signalling inhibition was shown to
facilitate the initial reprogramming stages [55]. However,
it is unknown whether this mechanism is connected to
endogenous Oct4 activation during reprogramming. In
addition, E-cadherin was recently identified as an impor-
tant downstream Oct4 effector in establishing cell adhe-
sion properties required to maintain a pluripotent state
[56], which may represent another Oct4 mechanism in
reprogramming.
Overcoming epigenetic barriers
According to the current view, reprogramming initiation
represents a stochastic process during which reprogram-
ming factors bind the genome promiscuously and act as
‘pioneer’ factors opening up the repressed chromatin and
recruiting other transcriptional activators and chromatin
remodellers as well as the transcriptional machinery [57–
59] (Figure 1B). Indeed, most of the genomic sites bound by277
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Figure 1. Potential Oct4 mechanisms in reprogramming. (A) Oct4 facilitates the mesenchymal-to-epithelial transition (MET) via repression of TGFbR3 and TGFb3 and
activation of the miR-200 family of miRNAs, which lead to repression of the epithelial-to-mesenchymal transition (EMT) regulators Snail and Zeb2, respectively. (B) During
reprogramming, Oct4, Sox2, and Klf4 act as ‘pioneer’ factors. They bind closed chromatin at distal gene regulatory regions in somatic cells before gene activation and
recruit other transcription factors and chromatin modifiers that can then facilitate gene reactivation. (C) Histone H3 lysine 9 (H3K9) methylation at the regulatory regions of
pluripotency genes presents a major roadblock to reprogramming, because it prevents the binding of reprogramming factors. Oct4 may be involved in overcoming this
barrier via activation of the H3K9 demethylases Jmjd1a and Jmjd2c. (D) The counterbalance of the lineage-specifying forces of Oct4 and Sox2 precludes the acquisition of
alternative cell states in reprogramming favouring the establishment of pluripotency. (E) Oct4 is required at high levels throughout the reprogramming process. However,
an embryonic stem (ES) cell level of Oct4 expression needs to be achieved at the latest reprogramming stages for a naı¨ve pluripotent state to be established.
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correspond to distal regulatory elements of genes embed-
ded in repressed chromatin in fibroblasts [58]. Some dere-
pression events may eventually occur leading to the
activation of early pluripotency genes and, therefore, pro-
gression towards the pluripotent state [57,60]. In support
of Oct4 pioneer activity, its overexpression in differentiat-
ed cells was shown to be sufficient to generate nucleosome-
depleted regions at the unmethylated Nanog and Oct4
regulatory sequences leading to basal gene reactivation
[61].
Despite the pioneer activity of reprogramming factors,
the chromatin of most pluripotency-associated genes is
initially inaccessible for binding, which was recently at-
tributed to the presence of the histone H3 lysine 9 tri-
methylation (H3K9me3) mark [58]. Consistently, global
H3K9me3 depletion enhances reprogramming [58,62]. Be-
cause Oct4 was demonstrated to be a potent activator of the
H3K9 demethylase Jmjd1a and Jmjd2c genes in mouse ES
cells [63], it could also be involved in surpassing this
epigenetic roadblock in reprogramming (Figure 1C).
Jmjd1a and Jmjd2c are known to maintain Tcl1 and Nanog
expression in ES cells through H3K9 demethylation at
their regulatory regions [63]. Moreover, the expression of
these two H3K9 demethylases increases during repro-
gramming [5] and their knock down inhibits efficient
iPS cell generation [62]. Also in support of this idea,
exogenous Oct4 can be replaced in the reprogramming
cocktail by the H3K9 methylase G9a inhibitor BIX-
01294 [64]. This may also occur at least in part through
reactivation of endogenous Oct4, because G9a is thought to
participate in heterochromatinisation of the Oct4 locus
[65]. However, in the absence of G9a, partial DNA methyl-
ation of the Oct4 locus and Oct4 repression still occur
during ES cell differentiation [66], suggesting that addi-
tional mechanisms contribute towards Oct4 repression.
Seesaw model of reprogramming
Recently, a ‘seesaw reprogramming and pluripotency mod-
el’ was proposed suggesting that pluripotency could be
established and maintained by counterbalancing the mu-
tually exclusive lineage-specifying forces of Oct4 and Sox2
[67–69] (Figure 1D). Particularly, Oct4 could inhibit the
ectodermal programme induced by Sox2. To counterbal-
ance, Sox2 could inhibit the mesendodermal programme
induced by Oct4. This model was proposed based on several
observations. First, it was recently demonstrated that
some mesendoderm-specific transcription factors (e.g.,
Gata6, Gata4, Sox7, Pax1, CEBPa, HNF4a) can replace
exogenous Oct4 in the initiation of reprogramming, where-
as some ectoderm-specific transcription factors (e.g., Sox1,
Sox3, Otx2, Pax6, Gmnn) can replace exogenous Sox2
[68,69]. Second, Oct4 overexpression in ES cells in se-
rum/leukaemia inhibitory factor (LIF) culture conditions
was found to induce the predominant formation of mesen-
dodermal lineages [7]. Third, Sox2 promotes neuroectoder-
mal differentiation of pluripotent cells [70,71] and drives
bipotential axial progenitors to a neuroectodermal cell fate
in the mouse embryo [72].
The seesaw model implies the existence of tight control
of the Oct4/Sox2 ratio, with deviations from such balancedirecting cells into alternative fates in the context of both
reprogramming and pluripotent cell maintenance [67–69].
Indeed, the importance of Oct4 and Sox2 levels for repro-
gramming and pluripotency maintenance is well estab-
lished [7,9,20,73–80]. However, alterations of these
levels in ES cells do not confirm the proposed idea of a
balance shift towards a particular lineage-specifying force.
Thus, pluripotent cells can be maintained with low levels of
Oct4 and wild type levels of Sox2 without upregulating
neuroectoderm markers and instead demonstrating en-
hanced self-renewal [80,81]. In addition, Sox2 loss in ES
cells can be rescued by ectopic expression of wild type levels
of Oct4 [9]. Also, Sox2 overexpression in ES cells can
generate a mixture of lineages including trophectoderm,
mesoderm, and neuroectoderm [20]. Moreover, the original
study showing that Oct4 overexpression induces predomi-
nant mesoderm and endoderm differentiation in ES cells
[7] was performed in the presence of serum containing
BMP4, a powerful inhibitor of neuroectoderm differentia-
tion [82,83]. Using the same Oct4 overexpression system
but under neural differentiation conditions, Oct4 acceler-
ated neural fate acquisition [84]. Furthermore, overexpres-
sion of Oct4 fused to a strong transactivation domain does
not induce the expression of mesendodermal genes and
does not cause differentiation of ES cells [85]. An alterna-
tive explanation for the capacity of lineage-specific master
transcriptional regulators to replace conventional repro-
gramming factors could be their ability to act as pioneer
factors. Indeed, it was demonstrated that Gata and HNF
factors possess a strong ability to open repressive chroma-
tin [59,86]. This may suggest that Oct4 and other repro-
gramming factors can be replaced as initiators of
reprogramming by any transcription regulator or chroma-
tin remodeller with pioneer activity. Another explanation
for pluripotency induction with lineage specifiers could be
their ability to upregulate endogenous pluripotency genes.
In support of this idea, Gata3 was shown to activate
endogenous Oct4 in reprogramming [69], whereas Gmnn,
an ectoderm specifier used to replace Sox2 in reprogram-
ming [68], was reported to be an important positive regu-
lator of pluripotency genes in ES cells [87]. To further
evaluate the seesaw reprogramming model, one should
compare the genomic occupancy of Oct4 and Sox2 with
that of lineage specifiers during reprogramming and ana-
lyse the effect of lineage specifiers on the upregulation of
the pluripotency network.
In summary, although there may be a place for a seesaw
mechanism in pluripotent state regulation, it is unlikely to
be a major determinant of cell fate.
Oct4 levels and cellular localisation in reprogramming
The functions of Oct4 in reprogramming are dose depen-
dent (Figure 1E). Several lines of evidence indicate that
transgenic Oct4 must be highly expressed in somatic cells
and reprogramming intermediates for successful repro-
gramming [76–80,88,89]. Low levels of transgenic Oct4
led to the generation of iPS cells with aberrant methylation
of the Dlk-Dio3 locus, tumourigenicity in chimeric mice,
and low capacity of tetraploid complementation. Impor-
tantly these could be corrected by increasing the levels of
exogenous Oct4 in reprogramming [76]. Another study279
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levels of Oct4 are refractory to pluripotency induction,
but can be rescued by increasing the OSKM transgene
copy number [89]. Therefore, the presence of high Oct4
levels at the initial reprogramming stage may assist in
opening chromatin, increasing the chances of reactivating
early pluripotency genes.
Recently, it was shown that an ES cell level of Oct4 must
be achieved at the late stages of reprogramming for cells to
enter the pluripotent cell state [80]. This requirement
specifically corresponds to the establishment of pluripo-
tency, because reduced Oct4 levels are compatible with
pluripotent cell self-renewal [80]. Notably, endogenous
Oct4 activation is not a predictor of pluripotency acquisi-
tion, because Oct4 is activated earlier than most of the core
pluripotency genes during reprogramming [33,73,88,90].
However, the reported reactivation of endogenous Oct4
may have been only partial and thus insufficient for repro-
gramming completion.
Besides expression levels, the cellular localisation of
Oct4 may also have biological importance. It was shown
that an Oct4 mutant actively exported from the nucleus
can rescue self-renewal of Oct4-null ES cells, but ineffi-
ciently induces reprogramming [91]. Interestingly, the
same study also described the weaker reprogramming
capacity of an Oct4 mutant fused to a strong nuclear
localisation signal. Although this result could be explained
by the reduced transactivation ability of this mutant [91],
the idea that Oct4 may have functions in the cytoplasm is
intriguing. Oct4 was shown to be a nucleocytoplasmic
shuttling protein [91,92] and was found in a complex with
b-catenin at the membrane of ES cells [93]. However, the
precise function of this complex and whether this occurs
during reprogramming is unknown.
Oct4 in cell differentiation
In addition to its role in pluripotency establishment, Oct4
was recently implicated in a contrasting cell state transi-
tion; that is, cell differentiation. It was proposed to be
involved in the acquisition of extraembryonic endoderm
cell fate and in pluripotent cell differentiation into embry-
onic lineages.
Oct4 was shown to orchestrate the patterning of primi-
tive endoderm during early mouse development by simul-
taneous activation of multiple primitive endoderm genes
[94]. In this study, Oct4-null embryos lost the capacity of
Gata6 expression by E4.0 and failed to acquire expression
of Sox17, Sox7, and platelet-derived growth factor receptor
a (Pdgfra), defining markers of the primitive endoderm
lineage [94]. Another recent study described the coopera-
tion of Oct4 with Sox17 for the activation of endoderm-
specific genes during in vitro specification of extraembry-
onic endoderm [95].
Oct4 overexpression studies in mouse ES cells
suggest that, depending on the culture environment used,
increases in Oct4 levels could induce or enhance cell dif-
ferentiation into various cellular lineages [7,70,80,84,96].
By contrast, Oct4 overexpression in human ES cells does
not lead to spontaneous differentiation or loss of pluripo-
tent cell identity [71]. Instead, Oct4-overexpressing human
ES cells exhibit enhanced endoderm and decreased neural280differentiation capacity when placed in corresponding dif-
ferentiation conditions [71]. It should be noted, however,
that overexpression-induced differentiation does not indi-
cate a requirement for Oct4 for specification of the formed
lineages or proves a negative role of Oct4 in the specifica-
tion of certain lineages, because overexpression pheno-
types could represent neomorphic effects. In fact, when
Oct4 is expressed constitutively at a wild type ES cell level
in pluripotent cells, they can efficiently enter embryonic
development and differentiate into progenitors of all three
embryonic lineages and germline in mouse embryos with-
out obvious bias [80]. This is somewhat opposed to both the
hypothesis that Oct4 may act as a blocker of certain cellu-
lar lineages [70,71,97] and the seesaw model for pluripo-
tency and reprogramming [67–69]. Importantly, it was
recently demonstrated that mouse iPS cells and ES cells
with decreased Oct4 levels can efficiently sustain self-
renewal but are incapable of germ layer differentiation
both in vitro and in vivo [80,81]. This proves the require-
ment of Oct4 for pluripotent cell differentiation. Impor-
tantly, the pattern of Oct4 expression in the embryo agrees
with these newly uncovered roles in cell differentiation. In
addition to pluripotent and germ cells, Oct4 is expressed in
the primitive endoderm of the blastocyst stage [98,99] and
in the progeny of all germ layers until the late somite stage
[100,101]. Moreover, using conditional Oct4 knockout it
was recently demonstrated that Oct4 is required for post-
implantation mouse development [102].
How can Oct4 govern such different processes as plur-
ipotency establishment, maintenance, and cell differenti-
ation? Most probably the answer to this seeming paradox
lies in the instructive role of the culture environment and
cellular context. Oct4 together with Nanog and Sox2 com-
prises the core of the pluripotency network [103]. These
master transcription factors together with Klf4, Esrrb,
and Mediator were found to co-occupy the recently classi-
fied super-enhancers, which are regulatory sequences
found associated with genes involved in the maintenance
of ES cell identity [104]. Counterintuitively, under differ-
entiation-inducing culture conditions, Oct4 participates
in the repression of pluripotency genes [80]. It is known
that the regulatory regions of pluripotency genes are also
bound by transcriptional repressor complexes (e.g., Lsd1–
NURD) [105]. Also, different Oct4 interactome studies in
ES cells demonstrated its interaction with chromatin
remodelling complexes, including Lsd1 and NURD
[106–108]. Thus, on stimulation with a differentiation
inducer, Oct4 may repress pluripotency genes via its
association with chromatin repressor complexes. This is
consistent with Oct4 typically being downregulated later
than other naı¨ve pluripotency-associated genes during ES
cell differentiation [80,109,110]. In support of this view, it
was demonstrated that Lsd1 and NURD are not required
for the maintenance of ES cell self-renewal, but are im-
portant for ES cell differentiation [111–113]. Thus, it will
be of future interest to assess the genomic occupancy of
both Oct4 and chromatin repressor complexes at early
stages of ES cell differentiation.
In addition to its potential role in the silencing of
pluripotency genes on induction of cell differentiation,
Oct4 is possibly involved in the upregulation of certain
Review Trends in Cell Biology May 2014, Vol. 24, No. 5lineage-specific genes, as was observed for extraembryonic
endoderm specification [94,95]. However, the continuous
requirement for Oct4 expression and the extent of Oct4
involvement in embryonic lineage differentiation requires
further investigation. In particular, it would be important
to address whether Oct4 has specific targets depending on
the cell lineage being acquired. This could indicate whether
Oct4 may act as a pioneer factor during cell differentiation,
providing competence for the establishment of new gene
expression patterns in development. This would unite the
seemingly contradictory roles of Oct4 in the acquisition and
loss of pluripotency.
Taken together, these results describe Oct4 as an es-
sential pan-regulator of cell commitment, potentially in-
volved in silencing of the pluripotency programme and the
establishment of lineage-specific gene expression identi-
ties instructed by environmental signals.
Oct4 in transdifferentiation
In addition to its described roles in reprogramming, plu-
ripotent cell self-renewal, and differentiation, Oct4 may
also induce transdifferentiation. It has been proposed that
human fibroblasts can transdifferentiate into multipotent
haematopoietic progenitors when Oct4 is ectopically
expressed in fibroblasts treated with cytokines [114]. Fur-
thermore, overexpression of Oct4, c-Myc, Sox2, and Klf4 in
combination with a culture environment supportive of the
target cell lineage allowed the conversion of mouse fibro-
blasts into contracting patches of cardiomyocytes [115],Naive
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E4.5 embryo 
Hypoblast
plur
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Figure 2. Oct4-controlled cell state transitions. Oct4, together with naı¨ve pluripotency sp
the naı¨ve pluripotent cell compartment in mouse E4.5 blastocysts and directs the repro
and Fgf signalling, Oct4 regulates specification of the primitive endoderm layer (hypob
stimulation with Fgf and other morphogens), Oct4 in combination with lineage specifieneural progenitors [116], and neural stem cells [117]. In all
of these studies, the authors provide experimental evi-
dence to exclude the possibility of Oct4 and other Yama-
naka factors transiently inducing pluripotent cells that
could later differentiate. However, a more extensive inves-
tigation utilising cells unable to establish pluripotency or
using permanent labelling of cells that have passed
through a pluripotent state is required to prove transdif-
ferentiation. The possibility that Oct4 and other Yama-
naka factors may induce transdifferentiation of various
somatic cell types is a further indication of their pioneer
activity in initiating the process that subsequently leads to
a cell state change.
Concluding remarks
Oct4 is an essential transcriptional regulator with multiple
and diverse functions during different stages of reprogram-
ming, pluripotency maintenance, cell differentiation, and
transdifferentiation (Figure 2). Although numerous recent
studies demonstrate the replacement of exogenous Oct4 by
other factors and compounds during reprogramming, most
Oct4 substitutions appear to act by upregulating the endog-
enous Oct4 locus (Table 1). This underscores the importance
of Oct4 in reprogramming, and future investigations
should focus on identifying and investigating its down-
stream functions.
Only recently was Oct4 implicated in cell differentia-
tion, calling for a revaluation of our views on how the
pluripotent state is controlled and how commitment isTRENDS in Cell Biology 
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signals have been identified and we have some knowledge
of what chromatin regulators participate in the establish-
ment of new gene expression patterns during differentia-
tion. However, the mechanisms of interconnection
between these ‘inducers’ and ‘executioners’ of cell differ-
entiation remain unknown. Could Oct4 be involved in
responding to differentiation-inducing stimuli by bring-
ing about specificity to the activity of epigenetic regula-
tors? This idea is intriguing and of interest to investigate
in the future.
In conclusion, we have summarised our current under-
standing of the roles of Oct4 in various aspects of repro-
gramming, pluripotency, and cell differentiation. The
emerging concept is that Oct4 is not merely a master
pluripotency self-renewal factor, but, in addition, a key
facilitator of cell state transitions occurring during cell
differentiation, reprogramming, and transdifferentiation
(Figure 2). In the future it would be important to define
Oct4 targets and interaction partners during different cell
state transitions. This will help in understanding how Oct4
function is regulated by the cellular context and/or extra-
cellular signalling and what role Oct4 plays at different
stages of reprogramming and in the initial specification of
different lineages.
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